Document:

eprs_EX_10_10

		
			Exhibit 10.10
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						EPIRUS BIOPHARMACEUTICALS, INC

				
	
					
						 

					
					
						ID: 04-3514457

				
	
					
						 

					
					
						699 Boylston St

				
	
					
						 

					
					
						8th Floor

				
	
					
						 

					
					
						Boston, MA 02116

				

		
			 
		

		
			Notice of Grant of Award and Award Agreement
		

		
			 
		

			
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						<<Name>>

					
					
						Award Number:

					
					
						<<Number>>

				
	
					
						<<Address>>

					
					
						Plan:

					
					
						2015

				

		
			 
		

		
			 
		

			
					
						 

				
	
					
						 

				
	
					
						 

				

		
			 
		

		
			 
		

		
			Effective <<Grant Date>>, you have been granted an award of <<Shares>> restricted stock units.  These units are restricted until the vest date(s) shown below, at which time you will receive shares of EPIRUS BIOPHARMACEUTICALS, INC (the Company) common stock.
		

		
			 
		

		
			 
		

		
			The current total value of the award is $<<Value>>.
		

		
			 
		

		
			 
		

		
			The award will vest in increments on the date(s) shown.
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

					
					
						Full Vest

				
	
					
						Shares

					
					
						 

					
					
						Date

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						<< Vest Date Shares >>

					
					
						 

					
					
						<<Vest Date>>

				

		
			 
		

		
			 
		

		
			 
		

		
			 
		

			
					
						 

				
	
					
						 

				
	
					
						 

				

		
			 
		

		
			By your signature and the Company's signature below, you and the Company agree that this award is granted under and governed by the terms and conditions of the Company's Award Plan as amended and the Award Agreement, all of which are attached and made a part of this document.
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						EPIRUS BIOPHARMACEUTICALS, INC

					
					
						 

					
					
						Date

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						<<Name>>

					
					
						 

					
					
						Date

				

		
			
		

		
			

		 

		

			 

		

 

		

			 

		

AWARD AGREEMENT
		

		
			 
		

		
			Granted Under the 2015 Equity Incentive Plan of EPIRUS Biopharmaceuticals, Inc.
		

		
			 
		

		
			This agreement, together with the Notice of Grant of Award to which this agreement is attached (collectively, this “Agreement”) governs the award (the “Award”) of restricted stock units granted by EPIRUS Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), on the date listed on the Notice of Grant of Award (the “Grant Date”) to the employee of the Company or its subsidiaries listed on the Notice of Grant of Award (the “Participant”) pursuant to the EPIRUS Biopharmaceuticals, Inc. 2015 Equity Incentive Plan (as amended from time to time, the “Plan”).
		

		
			 
		

		
			The Participant (i) hereby agrees to the terms of such Award, subject to the terms set forth in the Plan; (ii) further acknowledges receipt of a copy of the Plan as in effect on the date hereof; and (iii) agrees with the Company as follows: 
		

		
			 
		

		
			1. Effective Date. This Agreement shall take effect as of the date listed on the Grant Date. 
		

		
			 
		

		
			2. Grant of Award. The Award consists of such number of shares of common stock of the Company listed on the Notice of Grant of Award (each an “RSU” and collectively, the “RSUs”). Each RSU represents the right to receive one share of the common stock of the Company, $0.001 par value per share (“Stock”), as provided in this Agreement. The shares of Stock that are issuable upon vesting of the RSUs evidenced by this Agreement are referred to as “Shares.” 
		

		
			 
		

		
			3. Provisions of the Plan. This Award is subject to the provisions of the Plan, which are incorporated herein by reference. A copy of the Plan as in effect on the date of the grant of this Award has been furnished to the Participant. By accepting this Award, the Participant agrees to be bound by the terms of the Plan and this Agreement. All initially capitalized terms used herein will have the meaning specified in the Plan, unless another meaning is specified herein. 
		

		
			 
		

		
			4. Nontransferability of RSUs. The RSUs acquired by the Participant pursuant to this Agreement shall not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of except as provided below and in the Plan. 
		

		
			 
		

		
			5. Forfeiture Risk. Upon termination of the Participant’s Employment for any reason (including by death or disability), any unvested RSUs (after the application of Section 6 of this Agreement and any other applicable provision contained in this Agreement) and any Dividend 
		

		
			 
		

		
			
		

		
			

		 

		

			 

		

 

		

			 

		

Equivalents (as defined below) paid with respect thereto shall be automatically and immediately forfeited as of the date of such termination. 
		

		
			 
		

		
			6. Vesting of RSUs. The RSUs acquired hereunder shall vest according to the vesting schedule listed on the Notice of Grant of Award, subject to the Participant’s continued Employment at the vesting date.
		

		
			 
		

		
			7. Issuance of Shares.  
		

		
			 
		

		
			(a) Subject to the terms of the Plan and this Award, each RSU entitles the Participant to receive one share of Stock as soon as reasonably practicable following the vesting of the RSU, but in no event later than 30 days after such RSU vests. 
		

		
			 
		

		
			(b) The Shares shall be issued and delivered to the Participant in accordance with Section 7(a) upon compliance to the satisfaction of the Administrator with all requirements under applicable laws or regulations in connection with such issuance and with the requirements hereof and of the Plan. The determination of the Administrator as to such compliance shall be final and binding on the Participant. 
		

		
			 
		

		
			(c) Notwithstanding anything to the contrary herein or in the Plan, if the Participant is a “specified employee” within the meaning of Section 409A of the Code, and if any issuance of Shares hereunder is subject to the rule under Section 409A(a)(2)(B)(i) of the Code, then such issuance of Shares shall be delayed until the earlier of (i) the date that is six months and one day after the Participant has a “separation from service” as defined in Section 409A of the Code or (ii) the death of the Participant. 
		

		
			 
		

		
			8. Stockholder Rights, Dividends, etc. Until such time as shares of Stock are issued to the Participant pursuant to Section 7(a), the Participant shall have no rights as a stockholder with respect to any Shares underlying the RSUs, including, but not limited to, any voting rights, provided, however, that any dividends or other distributions paid with respect to the Shares underlying the RSUs (“Dividend Equivalents”) shall accrue and shall be converted into additional RSUs based on the closing price of the Stock on any such distribution date and any such additional RSUs shall be subject to the same conditions and restrictions as are the RSUs with respect to which they were paid. 
		

		
			 
		

		
			9. Certain Tax Matters. The Participant expressly acknowledges the following: 

		

		
			
		

		
			

		 

		

			 

		

 

		

			 

		

(a) The Participant acknowledges that no election under Section 83(b) of the Code may be filed with respect to this Award. 
		

		
			 
		

		
			(b) In circumstances in which tax withholding is applicable upon the vesting of the RSUs acquired hereunder, the Company shall retain from the Shares otherwise deliverable to the Participant a number of Shares having a fair market value (as determined by the Administrator) equal to the Participant’s tax obligation; provided, however, that the total tax withholding using Shares may not exceed the Company’s statutory minimum withholding obligation. Notwithstanding the foregoing, the Company may, in its sole discretion, require the Participant to satisfy the withholding obligation with cash. 
		

		
			 
		

		
			10. Miscellaneous.  
		

		
			 
		

		
			(a) Notice hereunder shall be given to the Company at its principal place of business and shall be given to the Participant at the address set forth below, or in either case, at such other address as one party may subsequently furnish to the other party in writing. 
		

		
			 
		

		
			(b) This Award does not confer upon the Participant any rights with respect to continuation of service as an employee or director of the Company.eprs_EX_10_16

		
			Exhibit 10.16
		

		
			 
		

		
			EPIRUS BIOPHARMACEUTICALS, INC. 
		

		
			AMENDED AND RESTATED
		

		
			Non-Employee DIRECTOR COMPENSATION POLICY
		

		
			 
		

		
			Non-employee members of the board of directors (the “Board”) of EPIRUS Biopharmaceuticals, Inc. (the “Company”) shall be eligible to receive cash and equity compensation as set forth in this Amended and Restated Non-Employee Director Compensation Policy (this “Policy”).  The cash and equity compensation described in this Policy shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a “Non-Employee Director”), who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company.  This Policy shall be effective as of the date of the annual meeting of the Company’s stockholders (each such annual meeting, an “Annual Meeting”) that occurs in 2015 (the “Effective Date”) and shall remain in effect until it is revised or rescinded by further action of the Board.  This Policy may be amended, modified or terminated by the Board at any time in its sole discretion and shall be reviewed by the Board annually.  The terms and conditions of this Policy shall supersede the Non-Employee Director Compensation Policy adopted by the Company on July 15, 2014 and any other prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors and between any subsidiary of the Company and any of its non-employee directors. 
		

		
			1.           Cash Compensation.  
		

		
			(a)          Annual Board Retainers.  
		

		
			(i)          Chairman.  The Chairman of the Board shall receive an annual retainer of $60,000 for service on the Board.  
		

		
			(ii)         All Other Non-Employee Directors.  Each Non-Employee Director other than the Chairman shall receive an annual retainer of $40,000 for service on the Board.
		

		
			(b)          Annual Committee Retainers.  
		

		
			(i)          Audit Committee.   A Non-Employee Director serving as Chairperson of the Audit Committee shall receive an additional annual retainer of $15,000 for such service.    A Non-Employee Director serving as a member of the Audit Committee (other than the Chairperson) shall receive an additional annual retainer of $7,500 for such service.
		

		
			(ii)         Compensation Committee.  A Non-Employee Director serving as Chairperson of the Compensation Committee shall receive an additional annual retainer of $10,000 for such service.    A Non-Employee Director serving as a member of the Compensation Committee (other than the Chairperson) shall receive an additional annual retainer of $5,000 for such service.
		

		
			(iii)        Corporate Governance and Nominating Committee.   A Non-Employee Director serving as Chairperson of the Corporate Governance and Nominating Committee shall receive an additional annual retainer of $7,500 for such service.  A Non-Employee Director serving as a member of the Corporate Governance and Nominating Committee (other than the Chairperson) shall receive an additional annual retainer of $3,500 for such service.
		

		
			(c)          Payment of Retainers.  The annual retainers described in Sections 1(a) and 1(b) shall be earned on a quarterly basis based on a calendar quarter and shall be paid by the Company in 
		

		
			 
		

		
			
		

		
			

		 

		

			1

		

 

arrears not later than the fifteenth day following the end of each calendar quarter.  In the event a Non-Employee Director does not serve as a Non-Employee Director, or in the applicable positions described in Section 1(b), for an entire calendar quarter, such Non-Employee Director shall receive a prorated portion of the retainer(s) otherwise payable to such Non-Employee Director for such calendar quarter pursuant to Section 1(b), with such prorated portion determined by multiplying such otherwise payable retainer(s) by a fraction, the numerator of which is the number of days during which the Non-Employee Director serves as a Non-Employee Director or in the applicable positions described in Section 1(b) during the applicable calendar quarter and the denominator of which is the number of days in the applicable calendar quarter.
		

		
			 
		

		
			2.           Equity Compensation.  Non-Employee Directors shall be granted the equity awards described below.  The awards described below shall be granted under and shall be subject to the terms and provisions of the Company’s Amended and Restated 2004 Incentive Plan or any other applicable Company equity incentive plan then-maintained by the Company (the “Equity Plan”) and shall be granted subject to the execution and delivery of award agreements, including attached exhibits, in substantially the forms previously approved by the Board.  All applicable terms of the Equity Plan apply to this Policy as if fully set forth herein, and all grants of stock options hereby are subject in all respects to the terms of the Equity Plan.    All stock options granted under this Policy shall be nonstatutory stock options, with an exercise price per share equal to 100% of the fair market value (as defined in the Equity Plan) of the underlying common stock of the Company on the date of grant, and a term of ten years from the date of grant (subject to earlier termination in connection with a termination of service as provided in the Equity Plan and the applicable award agreement). 
		

		
			(a)          Annual Awards.  A Non-Employee Director who (i) serves on the Board as of the date of any Annual Meeting (including the Effective Date) and (ii) will continue to serve as a Non-Employee Director immediately following the date of such Annual Meeting, shall be automatically granted, on the day immediately following the date of such Annual Meeting, a stock option to purchase 9,000 shares of the Company’s common stock  (with the number of stock options subject to adjustment as provided in the Equity Plan in each case).  The awards described in this Section 2(a) shall be referred to as the  “Annual Awards.”  A Non-Employee Director elected for the first time to the Board on the date of an Annual Meeting shall receive only an Initial Award in connection with such election, and shall not receive any Annual Award on the day immediately following the date of such Annual Meeting.
		

		
			(b)          Initial Awards. Except as otherwise determined by the Board, each Non-Employee Director who is initially elected or appointed to the Board after the Effective Date on any date other than an Annual Grant Date shall be automatically granted, on the date of such Non-Employee Director’s initial election or appointment (such Non-Employee Director’s “Start Date”),  a stock option to purchase 14,000 shares of the Company’s common stock (with the number of stock options subject to adjustment as provided in the Equity Plan in each case).  The awards described in this Section 2(b) shall be referred to as “Initial Awards.”  No Non-Employee Director shall be granted more than one Initial Award.
		

		
			(c)          Termination of Service of Employee Directors.  Members of the Board who are employees of the Company or any parent or subsidiary of the Company who subsequently terminate their service with the Company and any parent or subsidiary of the Company and remain on the Board shall  not receive an Initial Award pursuant to Section 2(c) above, but to the extent that they are otherwise eligible, shall be eligible to receive, after termination from service with the Company and any parent or subsidiary of the Company, Annual Awards as described in Section 2(b) above.
		

		
			(d)          Vesting of Awards Granted to Non-Employee Directors.  Vesting of the equity awards to Non-Employee Directors shall be as follows:  (i) Initial Awards shall vest and become exercisable over a three-year period in equal monthly installments, and (ii) Annual Awards shall vest and 
		

		
			 
		

		
			
		

		
			

		 

		

			2

		

 

become exercisable over a one-year period in equal quarterly installments.    No portion of an Annual Award or Initial Award that is unvested or unexercisable at the time of a Non-Employee Director’s termination of service on the Board shall become vested and exercisable thereafter.  All of a Non-Employee Director’s Annual Awards and Initial Awards shall vest in full immediately prior to the occurrence of a Covered Transaction (as defined in the Equity Plan), to the extent outstanding at such time.  
		

		
			3.           Business Expense Reimbursement.  Each Non-Employee Director shall be entitled to reimbursement of such Director’s reasonable business expenses incurred on behalf of the Company, upon presentation of documentation acceptable to the Board.
		

		
			 
		

		
			* * * * *
		

		 

		

			3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00256-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00256-of-00352.parquet"}]]